Press Releases
Newsletters
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
AGT Newsletter Volume 7
Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
AGT Newsletter Volume 6
NEWSLETTER VOL. 6 AGT’s progress over the first half of 2018 has been tremendous: six patents granted, major advances in all of its key projects: HIV, PKU and immuno-oncology, substantial momentum on socia...
Latest Videos
Published Articles
Latest From The Blog
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
June 8th: @IAmBiotech will go #BIODigital and broadcast company insights for continued research and development. @jeffreygalvin will present AGT's #HIV cure research data. Watch a sneak peek of his presentation: https://t.co/ozuU1E2sH8
If not registered, DM for more details.
On this #MemorialDay we want to thank the brave men and women who put their lives on the line for our #freedom. Thank you from the bottom of our hearts. Our thoughts are with those who cannot be with family in these trying times. We wish everyone a safe holiday. #MDW #MDW2020 https://t.co/j9Kf62ROj7
With our patents and process in place, we are finally able to share details of our #HIV cure program in a peer-reviewed article in @MolTherapy 👉 https://t.co/RTdpNpbJRn
About our HIV Program https://t.co/jl4aATgUWv
#GeneTherapy #CellTherapy #Science #ScienceNews #Biotech https://t.co/4u4YNcSxqR
